Skip to main content
. 2019 Feb 5;8(2):187. doi: 10.3390/jcm8020187

Figure 1.

Figure 1

Moscatilin inhibited esophageal cancer tumor growth in vivo. The tumor size observed in the moscatilin-treated group (50 mg/kg) decreased significantly compared with tumor size in the control group * p < 0.05 (a). Representative photographs of tumor specimens of control and moscatilin-treated mice, as indicated (b).